News | PACS | March 14, 2018

Fujifilm Showcases Enterprise Imaging Portfolio and AI Initiative at HIMSS 2018

Fujifilm is working to integrate artificial intelligence to improve workflow in its Synapse 5 PACS

Fujifilm Showcases Enterprise Imaging Portfolio and AI Initiative at HIMSS 2018

March 14, 2018 — Fujifilm Medical Systems U.S.A. Inc. recently showcased its enterprise imaging and informatics solutions at the Healthcare Information and Management Systems Society’s (HIMSS) Annual Conference and Exhibition, held March 5-9, 2018 in Las Vegas. In addition to its extensive product portfolio, Fujifilm announced the expansion of its Artificial Intelligence (AI) Research Project into the U.S. market. Fujifilm’s AI development initiative will harness the power of AI to enhance its Synapse Enterprise Imaging and Medical Informatics portfolio. The company also introduced its newest brand REiLI, which will represent Fujifilm’s global Medical Informatics and Imaging AI technology Initiative.

Fujifilm’s Artificial Intelligence Research Project is based in Raleigh, N.C. — the global development headquarters for the Synapse Enterprise Imaging portfolio — in collaboration with Fujifilm Corp.’s development team in Tokyo that will provide a wide range of image recognition technologies. Fujifilm will partner with its strategic customers in the U.S. market to draw upon clinical insights and expertise to bridge AI applications to imaging informatics solutions. In an increasingly complex healthcare environment with massive datasets and rising demand for high-quality care, AI technology will have the potential to change the practice of medicine, according to the company.

Fujifilm Vice President of Medical informatics Bill Lacy said the company has received very positive feedback from healthcare professionals that have already seen live demonstrations of the AI Research Project, specifically regarding the speed and depth of integrated workflow achieved with the Synapse 5 server-side picture archiving and communication system (PACS).

“As we focus initially on radiology, and with a clear focus on supporting and collaborating with radiologists, not replacing them, artificial intelligence technology can help radiologists aggregate PHI faster for more informed decisions, and prioritize their work and time more effectively,” he added.

More information on Fujifilm’s AI Research Project was demonstrated at the company’s HIMSS booth alongside the following products:  

Synapse VNA — At the core of Fujifilm's comprehensive Enterprise Imaging portfolio, the TeraMedica division of Fujifilm’s Synapse VNA (vendor neutral archive) integrates more specialties, more devices and more data than any other VNA, according to the company. Healthcare organizations can achieve cost savings, improve clinical outcomes, optimize workflow efficiencies, securely manage all departmental data and experience imaging interoperability through the combination of Synapse VNA, Synapse Mobility Enterprise Viewer and Virtual Image Exchange.

Synapse 5 PACS — Designed with speed and functionality in mind, Synapse 5 PACS is a next-generation, secure server-side technology that enables instant access of massive datasets, working within the most popular browsers while using less bandwidth throughout the enterprise. Synapse 5 PACS powered with Synapse Communications features an enhanced suite of integrated tools including an integrated point-of-care solution, emergency department findings, results escalation and tracking, radiologist peer review, helping create a tailored workflow and a closed loop of communication between the radiology and all clinical departments.

Synapse RIS — Synapse RIS (radiology information system) helps radiology facilities take command of their operations. Synapse RIS is a full-featured workflow management system that is fully integrated with Synapse 5 PACS. It features an advanced scheduling intelligence engine, a patient portal, business intelligence analytics and productivity-boosting tools that include universal worklist and paperless consent forms. With its flexible architecture and modern interoperability standards, Synapse RIS allows practices to easily integrate with physicians in their community.

Synapse Cardiovascular — Developed with ongoing direction from cardiologists, Synapse Cardiovascular offers capabilities and tools that help streamline, image review and reporting across cardiac catheterization, electrocardiogram (ECG) management, echocardiography, nuclear cardiology, 3-D imaging and vascular ultrasound workflows.

Synapse 3-D — Designed for use across multiple specialties including radiology, cardiology, surgery and more, Synapse 3-D is an enterprise-wide solution for quickly performing advanced visualization workflows and accessing 3-D-rendered images. Full integration with Synapse 5 PACS and Synapse Cardiovascular allows one-click access from any Synapse client.

Synapse Cloud Services — A scalable environment shaped to host and manage the Synapse Enterprise Imaging portfolio. Critical-access hospitals, imaging centers and teleradiology providers can take advantage of Fujifilm’s cloud-based infrastructure and interoperability of software to maximize efficiency and cost savings.

For more information: www.fujimed.com

 

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once
News | Artificial Intelligence | April 02, 2020
April 2, 2020 — In the face of the COVID-19 pand
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe
News | Artificial Intelligence | March 31, 2020
March 31, 2020 — Lung infections generated by the coronavirus can be detected in...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Doctor in our hospital is using this intelligent system for accurate diagnosis

Doctor in our hospital is using this intelligent system for accurate diagnosis. (Photo: Business Wire)

News | Artificial Intelligence | March 31, 2020
March 31, 2020 — The Intelligent Evalua...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 behold.ai has developed the artificial intelligence-based red dot algorithm which can identify within 30 seconds abnormalities in chest X-rays. Wellbeing Software operates Cris, a widely used UK radiology Information System (RIS), which is installed in over 700 locations
News | Artificial Intelligence | March 31, 2020
March 31, 2020 — Two British companies at the leading edge of medical imaging technology are working together on a pl